Skip to content

Drug interactions

Deferiprone + Eltrombopag

Severity: Moderate

Deferiprone and Eltrombopag: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Deferiprone is cleared mainly by UGT1A6 glucuronidation, and eltrombopag can inhibit UGT1A6 in vitro, so deferiprone exposure might increase. Deferiprone can cause agranulocytosis, so higher exposure is of concern.

What this interaction means in plain words

Deferiprone and Eltrombopag can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Deferiprone belongs to Miscellaneous; Eltrombopag belongs to Miscellaneous.

Evidence level: Low

Why it happens

Inhibition of UGT1A6-mediated glucuronidation of deferiprone by eltrombopag.

What to do

Monitor absolute neutrophil count closely and watch for signs of infection. Reduce the deferiprone dose if neutropenia develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Deferiprone and Eltrombopag, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Deferiprone with Eltrombopag?

MediHelp rates the interaction as moderate. Deferiprone and Eltrombopag can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Deferiprone is cleared mainly by UGT1A6 glucuronidation, and eltrombopag can inhibit UGT1A6 in vitro, so deferiprone exposure might increase. Deferiprone can cause agranulocytosis, so higher exposure is of concern.

How serious is the interaction between Deferiprone and Eltrombopag?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor absolute neutrophil count closely and watch for signs of infection. Reduce the deferiprone dose if neutropenia develops.

What other medicines interact with Deferiprone?

MediHelp also lists interactions of Deferiprone with, for example, Clozapine, Abemaciclib, Acalabrutinib. The full list is on the Deferiprone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in